U.S. Home Infusion Therapy Market – By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-Infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty) – Forecast 2024 – 2032

U.S. Home Infusion Therapy Market – By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-Infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty) – Forecast 2024 – 2032

U.S. Home Infusion Therapy Market Size

U.S. Home Infusion Therapy Market size was valued at USD 12.4 billion in 2023 and is expected to exhibit growth at a CAGR of 10.1% from 2024 to 2032. High market growth can be attributed to the ongoing advancements in medical technology, rising prevalence of chronic diseases, growing hospital acquired infections, and rising geriatric population, among other contributing factors.

To get key market trends

  Download Free Sample

Home infusion therapy refers to the administration of medications and biologicals intravenously or via other non-oral routes, such as subcutaneously, in a patient’s home. This therapy is designed to treat a wide range of medical conditions, including infections, dehydration, gastrointestinal diseases, and chronic diseases that require long-term drug administration.
The aging demographic in the U.S. increases the prevalence of chronic diseases and conditions that require ongoing medical treatment. Elderly patients often prefer home-based care to institutional settings, contributing to the demand for home infusion therapy. For instance, according to the data published by Population Reference Bureau (PRB), the number of Americans aged 65 and older is expected to climb from 58 million in 2022 to 82 million by 2050. Thus, growth in the elderly population fuels demand for home healthcare services, including infusion therapy, as part of comprehensive disease management strategies.

Furthermore, integration of infusion devices with digital health platforms and telehealth solutions enhances remote monitoring and management of patients receiving home infusion therapy. Connectivity enables real-time data transmission, remote patient monitoring, and proactive healthcare interventions. Improved patient outcomes, reduced hospital readmissions, and operational efficiencies drive adoption of technologically integrated home infusion solutions.

What are the growth opportunities in this market?

 Download Free Sample

U.S. Home Infusion Therapy Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as expansion of indications and therapies, continuous innovations in infusion devices, rise of specialty pharmacy services, and growing demand for integrated telehealth services, among other factors are propelling the industry growth.

• Further, there is growing demand for expanding the range of therapies suitable for home infusion. Traditionally limited to antibiotics and hydration therapies, home infusion now includes complex treatments such as immunoglobulin therapy, chemotherapy, parenteral nutrition, and biologic therapies. Broader indications expand the market potential and allow patients with diverse medical conditions to receive specialized care at home, enhancing convenience and improving quality of life.
• Moreover, ongoing advancements in infusion pump technology, catheters, and connected devices improve the safety, accuracy, and reliability of home infusion therapy. Smart pumps with integrated software enable precise drug delivery, remote monitoring, and real-time data collection.
• Enhanced technology adoption supports the expansion of home infusion therapies by optimizing therapy management, minimizing complications, and enabling healthcare providers to deliver personalized care remotely, thereby driving the demand for home infusion therapy.

U.S. Home Infusion Therapy Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on product, the market is classified into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pumps generated the highest revenue of around USD 6.2 billion in 2023.

• Infusion pumps play a crucial role in ensuring patient safety by delivering medications accurately and minimizing the risk of medication errors. Advanced features such as dose rate monitoring, occlusion detection, and alarm systems enhance device reliability and treatment adherence.
• Emphasis on patient safety and treatment outcomes drives the adoption of infusion pumps in home infusion therapy, supporting healthcare providers in delivering high-quality care and reducing healthcare-associated complications.
• Moreover, there is an increasing awareness and acceptance of home infusion therapy among patients and healthcare professionals. Educational initiatives and success stories of home-based treatments are encouraging more patients to opt for home infusion, driving the market for infusion pumps, thereby leading to the segment growth.

Learn more about the key segments shaping this market

 Download Free Sample

Based on application, the U.S. home infusion therapy market is classified into anti-infectives, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and other applications. The anti-infectives segment dominated the market in 2023 with a market share of 27.1%.

• There is a significant shift towards home-based healthcare, driven by patient preferences for receiving treatment in the comfort of their own homes. This trend is further fueled by healthcare providers' efforts to reduce hospital overcrowding and minimize the risk of hospital-acquired infections. Home infusion therapy for anti-infectives aligns with this trend, offering a safe and effective alternative to inpatient care.
• Furthermore, the expansion and improvement of home healthcare services, including better training for home healthcare providers and comprehensive support systems, facilitate the safe administration of anti-infective therapy at home. A robust home healthcare infrastructure ensures high-quality care, making home infusion a viable and effective option.

Looking for region specific data?

 Download Free Sample

The South Atlantic home infusion therapy market accounted for USD 2.6 billion market revenue in 2023 and is anticipated to grow at CAGR of 10.3% between 2024 – 2032 period.

• The zone, which includes states like Florida, Georgia, and North Carolina, has a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. These conditions often require long-term intravenous (IV) therapies, making home infusion therapy a crucial service. The rising incidence of these chronic conditions drives the demand for home infusion therapy.
• Moreover, advancements in infusion technology, such as portable and user-friendly infusion pumps, have made it easier and safer for patients to receive treatments at home. These technological improvements ensure accurate and reliable drug delivery, enhancing patient safety and treatment outcomes. The availability of advanced infusion devices supports the growth of the home infusion therapy market in the zone.

New York home infusion therapy market is projected to grow remarkably in the coming years.

• The state has a large population with a growing segment of elderly residents. The aging population is more prone to chronic conditions and complex healthcare needs, necessitating continuous medical care.
• The demographic trend of an aging population drives demand for home-based healthcare solutions, including infusion therapy, to manage chronic conditions and maintain quality of life.

California holds a dominant position in the Pacific Central home infusion therapy market.

• California is known for its advanced healthcare infrastructure, including leading medical institutions, research centers, and biotech companies. The state is also a hub for technological innovation, particularly in healthcare technology.
• The presence of advanced healthcare facilities and a strong focus on innovation facilitate the adoption of sophisticated home infusion therapies, leveraging the latest technologies to improve patient outcomes. This is expected to boost the market growth in the state.

U.S. Home Infusion Therapy Market Share

The market is characterized by the presence of several key players, including large healthcare companies, specialized home infusion service providers, and regional healthcare organizations. These companies focus on expanding their geographic presence, enhancing service capabilities, and forming strategic partnerships to gain market share. Additionally, technological advancements, particularly in infusion pumps and telehealth integration, drive innovation and competition. Smaller regional providers and niche players also contribute to the market by offering specialized services and personalized care, fostering a dynamic and competitive environment.

U.S. Home Infusion Therapy Market Companies

Prominent players operating in the home infusion therapy industry include

• AMERITA INC.
• Amsino International, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• Contec Medical Systems Co. Ltd
• Erenler Medikal
• Fresenius Kabi Ag
• Halyard Health, Inc. (Avanos Medical)
• ICU Medical Inc.
• JMS Co. Ltd.
• Lepu Medical Technology
• Moog Inc.
• Option Care Health, Inc.
• Terumo Corporation

Home Infusion Therapy Industry News

• In February 2024, Dynamic Access, LLC announced the launch of Dynamic Infusion, a new affiliate brand that offer home infusion nursing services to patients with chronic diseases such as autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, multiple sclerosis, and others. It will support the operations of two heritage firms, each with over ten years of expertise supplying home infusion nursing services to patients throughout the Northeast.
• In April 2024, Baxter International Inc. announced that its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software has received 510(k) approval from the U.S. Food and Drug Administration. It allows clinicians to use a single, integrated system across a wide range of patient care settings. Offering the Novum IQ LVP in the U.S. underscores Baxter's commitment to ongoing innovation in infusion treatment.

The U.S. home infusion therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Infusion pumps
• Intravenous sets
• IV cannulas
• Needleless connectors

Market, By Application

• Anti-infectives
• Hydration therapy
• Chemotherapy
• Enteral nutrition
• Parenteral nutrition
• Specialty pharmaceuticals
• Other applications

The above information is provided for the following regions and countries

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Centra
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming